M. Mugnaini

发表

The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence

J. Hagan, P. Thanos, Z. Xi, 2005, Brain Research Reviews.

3‐[(±)‐2‐Carboxypiperazin‐4‐yl]propyl‐1‐Phosphonic Acid Recognizes Two N‐Methyl‐D‐Aspartate Binding Sites in Rat Cerebral Cortex Membranes

M. Mugnaini, E. Ratti, F. Amsterdam, 1992, Journal of neurochemistry.

Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist

Alan A. Wilson, S. Houle, M. Laruelle, 2010, Biological Psychiatry.

1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines: A Series of Potent and Selective Dopamine D3 Receptor Antagonists

J. Hagan, A. Schwarz, A. Capelli, 2007 .

The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL/6J mice

David R. Willé, Sam R. Miller, E. Bullmore, 2015, Psychopharmacology.

Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists

A. Capelli, C. Gotti, M. Mugnaini, 2011, British journal of pharmacology.

Allosteric Modulation of [3H]CGP 39653 Binding by Glycine in Rat Brain

M. Mugnaini, E. Ratti, F. Amsterdam, 1993, Journal of neurochemistry.

Substituted Indole‐2‐carboxylates as Potent Antagonists of the Glycine Binding Site Associated with the NMDA Receptor

M. Mugnaini, F. Micheli, R. Di Fabio, 1999, Archiv der Pharmazie.

Nicotinic Acetylcholine Receptors in the Mesolimbic Pathway: Primary Role of Ventral Tegmental Area α6β2* Receptors in Mediating Systemic Nicotine Effects on Dopamine Release, Locomotion, and Reinforcement

V. Tedesco, C. Chiamulera, M. Zoli, 2010, The Journal of Neuroscience.

Receptor distribution studies

R. Carletti, S. Tacconi, M. Mugnaini, 2017, Current opinion in pharmacology.

Molecular and Behavioral Aspects of Nicotine Dependence and Reward

E. Pich, C. Heidbreder, M. Mugnaini, 2003 .

Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site.

A. Capelli, G. Tedesco, G. Gaviraghi, 1997, Journal of medicinal chemistry.

Allosteric Interactions at the NMDA Receptor Channel Complex

M. Mugnaini, 2006 .

Allosteric modulation of [3H]‐CGP39653 binding through the glycine site of the NMDA receptor: further studies in rat and human brain

N. Bowery, M. Corsi, M. Mugnaini, 2001, British journal of pharmacology.

The Use of Knock-Out Mice Unravels Distinct Roles for mGlu2 and mGlu3 Metabotropic Glutamate Receptors in Mechanisms of Neurodegeneration/Neuroprotection

F. Nicoletti, A. Pittaluga, C. Corti, 2007, The Journal of Neuroscience.

Receptor binding characteristics of the novel NMDA receptor glycine site antagonist [3H]GV150526A in rat cerebral cortical membranes.

M. Corsi, M. Mugnaini, B. Bunnemann, 2000, European journal of pharmacology.

[3H]MK-801 binding and the mRNA for the NMDAR1 subunit of the NMDA receptor are differentially distributed in human and rat forebrain.

D G Trist, N. Bowery, M. Mugnaini, 1998, Brain research. Molecular brain research.

[3H]5,7-dichlorokynurenic acid recognizes two binding sites in rat cerebral cortex membranes.

M. Corsi, M. Mugnaini, F. V. van Amsterdam, 1998, Journal of receptor and signal transduction research.

GV150526: A Neuroprotective Agent

F. Bordi, A. Reggiani, R. Barnaby, 2006 .

Upregulation of [3H]methyllycaconitine binding sites following continuous infusion of nicotine, without changes of α7 or α6 subunit mRNA: an autoradiography and in situ hybridization study in rat brain

C. Chiamulera, M. Tessari, M. Mugnaini, 2002, The European journal of neuroscience.

Dopamine responsiveness to drugs of abuse: A shell‐core investigation in the nucleus accumbens of the mouse

M. Lennon, C. Heidbreder, M. Mugnaini, 2003, Synapse.

Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist

John D. Beaver, Mark Slifstein, Marc Laruelle, 2010, Biological Psychiatry.

Occupancy of Brain Dopamine D3 Receptors and Drug Craving: A Translational Approach

E. Rabiner, E. Pich, J. Beaver, 2013, Neuropsychopharmacology.

Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.

A. Reggiani, F. Belardetti, M. Corsi, 1999, The Journal of pharmacology and experimental therapeutics.

Pharmacological analysis of carboxyphenylglycines at metabotropic glutamate receptors.

F. Ferraguti, M. Mugnaini, D. Trist, 1994, European journal of pharmacology.

A Comparative Study of the Effects of the Intravenous Self-Administration or Subcutaneous Minipump Infusion of Nicotine on the Expression of Brain Neuronal Nicotinic Receptor Subtypes

M. Zoli, C. Gotti, F. Clementi, 2010, Molecular Pharmacology.

Selective down-regulation of [125I]Y0-α-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine

M. Pilla, C. Heidbreder, M. Tessari, 2006, Neuroscience.

Regionally different N‐methyl‐D‐aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]‐CGP 39653 in rat brain

N. Bowery, M. Mugnaini, D. Trist, 1996, British journal of pharmacology.

GV 196771A, a New Glycine Site Antagonist of the NMDA Receptor with Potent Antihyperalgesic Activity

M. Corsi, M. Mugnaini, D. Trist, 2003 .

IN RAT CEREBRAL CORTEX MEMBRANES

M. Corsi, M. Mugnaini, M. Antolini, 1998 .

1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.

A. Capelli, G. Tedesco, F. Blaney, 2010, Journal of medicinal chemistry.

Transient forebrain over-expression of CRF induces plasma corticosterone and mild behavioural changes in adult conditional CRF transgenic mice

C. Large, E. Domenici, I. Mansuy, 2009, Pharmacology Biochemistry and Behavior.

The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence

J. Hagan, P. Thanos, Z. Xi, 2005, Brain Research Reviews.